Mesalamine: Clinical Trials

21 trials of Mesalamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 3 not yet recruiting, 3 unknown, 1 recruiting. 21 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 421Completed 13, Not yet recruiting 3, Unknown 3, Recruiting 1, Terminated 1

Follow Mesalamine: new trials by email Literature Review of Mesalamine trials Research Report on Mesalamine

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC
Etrasimod, mesalazine - Etrasimod, Mesalazine
Phase 4Not yet recruitingSir Run Run Shaw Hospital3202026-07-312026-08-24
Combined Application of EEN in the Induction of Remission in PUC
exclusive enteral nutrition, regular food - Exclusive Enteral Nutrition, Ulcerative Colitis
Phase 4Not yet recruitingChildren's Hospital of Fudan University402025-03-012024-07-03
TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS
Tofacitinib, Tofacitinib plus mesalamine - Ulcerative Colitis
Phase 4Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh752024-10-012024-10-03
Role of Roflumilast in Ulcerative Colitis
Roflumilast 500 MCG Oral Tablet [DALIRESP], amino salicylic acid - Ulcerative Colitis
Phase 4CompletedTanta University522023-02-012025-01-28
Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
Infliximab, Vedolizumab, Mesalazine - Ulcerative Colitis, Efficacy, Self
Phase 4CompletedSixth Affiliated Hospital, Sun Yat-sen University4382022-01-152026-04-29
Top Down Versus Step up in Pediatric Ulcerative Colitis
Infliximab, Corticosteroids - Ulcerative Colitis, Infliximab
Phase 4RecruitingChildren's Hospital of Fudan University402021-11-012024-02-28
Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis
Mesalazine - Ulcerative Colitis
Phase 4UnknownFlemming Bendtsen2002019-11-282023-09-26
Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis
Mesalazine, hydrocortisone sodium succinate, Mesalazine with hydrocortisone sodium succinate - Ulcerative Colitis, Unspecified
Phase 4UnknownXijing Hospital of Digestive Diseases5282017-05-012017-04-12
Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis
oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone, corticosteroids only - Ulcerative Colitis
Phase 4CompletedSheba Medical Center1492013-09-012022-05-09
Cimzia Versus Mesalamine for Crohn's Recurrence
Cimzia, Mesalamine - Crohn's Disease
Phase 4TerminatedMilton S. Hershey Medical Center102013-02-012018-01-12
Predicting Response to Standardized Pediatric Colitis Therapy
Mesalazine, IV Corticosteroid, Oral Corticosteroids - Ulcerative Colitis
Phase 4CompletedConnecticut Children's Medical Center4312012-07-102019-09-20
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Mesalazine, Placebo - Irritable Bowel Syndrome With Diarrhoea
Phase 4CompletedUniversity of Nottingham1082011-03-012014-01-17
Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
Mesalamine - Mild to Moderate Ulcerative Colitis
Phase 4CompletedWolfson Medical Center862010-09-012015-12-08
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
MMX mesalamine/ mesalazine - Ulcerative Colitis
Phase 4CompletedShire7592010-06-292021-06-09
Mesalamine to Reduce T Cell Activation in HIV Infection
Mesalamine (5-aminosalicylic acid, Apriso), Placebo - HIV Infections, Sexually Transmitted Diseases
Phase 4CompletedUniversity of California, San Francisco332010-06-012014-08-13
Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon
Mesalazine plus Lactobacillus casei, Mesalazine placebo plus Lactobacillus casei placebo, Mesalazine 800 mg - Diverticular Disease of the Colon
Phase 4CompletedHospital Cristo Re2502009-01-012012-02-17
Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia
Mesalamine, DIET - Intestinal LNH
Phase 4UnknownAzienda Policlinico Umberto I2702008-11-012013-02-12
Dose Escalation and Remission (DEAR)
mesalamine - Ulcerative Colitis
Phase 4CompletedJames Lewis1192008-09-012015-05-05
Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
MMX Mesalamine - Ulcerative Colitis
Phase 4CompletedShire2902007-05-012021-06-14
The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
5-aminosalicylate (Pentasa, Ferring) - Crohn's Disease, Ulcerative Colitis
Phase 4CompletedAmsterdam UMC, location VUmc242005-07-012006-09-11

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Colitis, Ulcerative (16)  ·  Crohn Disease (2)  ·  Inflammatory Bowel Diseases (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Charcot-Marie-Tooth disease, Type 1C (1)  ·  Diarrhea (1)  ·  Food Hypersensitivity (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Lentivirus Infections (1)  ·  Patient Compliance (1)  ·  Recurrence (1)  ·  Sexually Transmitted Diseases (1)

Sponsors

Children's Hospital of Fudan University (2)  ·  Shire (2)  ·  Amsterdam UMC, location VUmc (1)  ·  Azienda Policlinico Umberto I (1)  ·  Connecticut Children's Medical Center (1)  ·  Flemming Bendtsen (1)  ·  Hospital Cristo Re (1)  ·  James Lewis (1)  ·  Milton S. Hershey Medical Center (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Sheba Medical Center (1)  ·  Sir Run Run Shaw Hospital (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Tanta University (1)  ·  University of California, San Francisco (1)

Countries

United States (7)  ·  China (4)  ·  Italy (3)  ·  Canada (2)  ·  France (2)  ·  Israel (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)

Top investigators

Ying Huang (2)  ·  Arie Levine, MD (1)  ·  Batia Weiss, MD (1)  ·  Dan Turner, MD, PhD (1)  ·  David B Stewart, MD (1)  ·  Flemming Bendtsen, MDSci (1)  ·  Giovanni Brandimarte, M.D. (1)  ·  James D Lewis, MD, MSCE (1)  ·  Jeffrey Hyams, MD (1)  ·  Lee Denson, MD (1)  ·  Ofir Har-Noy, MD (1)  ·  Robin C Spiller, MD (1)  ·  Ron Shaoul, MD (1)

Results publications

PMID 21837775, PMID 23957734, PMID 24793028, PMID 25193617, PMID 25545673, PMID 25765462, PMID 28939374, PMID 29361097, PMID 30294708, PMID 30935734, PMID 31373712, PMID 32801008, PMID 35272029, PMID 36871574, PMID 40955556, PMID 41043449, PMID 41105168

NIH funding

2009 (1), K24DK078228 (1), U34DK090804 (1)